newsfilter
← Latest News
GlobeNewswire·

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943

PALO ALTO, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (NASDAQ:VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting